pSivida Corp. Stock Price, News & Analysis (NASDAQ:PSDV)

$1.26 0.04 (3.28 %)
(As of 11/17/2017 12:38 PM ET)
Previous Close$1.26
Today's Range$1.21 - $1.26
52-Week Range$1.03 - $2.45
Volume468,232 shs
Average Volume920,817 shs
Market Capitalization$57.02 million
P/E RatioN/A
Dividend YieldN/A
Beta1.35

About pSivida Corp. (NASDAQ:PSDV)

pSivida Corp. logopSivida Corp. develops drug delivery products primarily for the treatment of chronic eye diseases. The Company operates through the biotechnology sector segment. The Company has developed three products for treatment of back-of-the-eye diseases, which include Medidur for posterior segment uveitis, its lead product candidate that is in pivotal Phase III clinical trials; ILUVIEN for diabetic macular edema (DME), its lead licensed product that is sold in the United States and European Union (EU) countries, and Retisert. Medidur is designed to treat chronic non-infectious uveitis affecting the posterior segment of the eye (posterior segment uveitis). ILUVIEN is an injectable micro-insert that provides treatment of DME from a single injection. Retisert is an implant that provides treatment of posterior segment uveitis. Its product development program is focused on utilizing its two technology platforms, Durasert and Tethadur, to deliver drugs and biologics to treat chronic diseases.


Industry, Sector and Symbol:
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Sector: Bio Therapeutic Drugs
  • Symbol: NASDAQ:PSDV
  • CUSIP: N/A
  • Web: www.psivida.com
Debt:
  • Current Ratio: 2.94%
  • Quick Ratio: 2.94%
Sales & Book Value:
  • Annual Sales: $7.54 million
  • Price / Sales: 7.56
  • Book Value: $0.20 per share
  • Price / Book: 6.30
Profitability:
  • Trailing EPS: ($0.46)
  • Net Income: ($18,480,000.00)
  • Net Margins: -226.31%
  • Return on Equity: -139.56%
  • Return on Assets: -99.99%
Misc:
  • Employees: 22
  • Outstanding Shares: 45,260,000
 

Frequently Asked Questions for pSivida Corp. (NASDAQ:PSDV)

What is pSivida Corp.'s stock symbol?

pSivida Corp. trades on the NASDAQ under the ticker symbol "PSDV."

How were pSivida Corp.'s earnings last quarter?

pSivida Corp. (NASDAQ:PSDV) announced its quarterly earnings results on Tuesday, November, 7th. The company reported ($0.15) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.15). The firm earned $0.39 million during the quarter, compared to analysts' expectations of $0.74 million. pSivida Corp. had a negative net margin of 226.31% and a negative return on equity of 139.56%. View pSivida Corp.'s Earnings History.

When will pSivida Corp. make its next earnings announcement?

pSivida Corp. is scheduled to release their next quarterly earnings announcement on Tuesday, February, 6th 2018. View Earnings Estimates for pSivida Corp..

Where is pSivida Corp.'s stock going? Where will pSivida Corp.'s stock price be in 2017?

6 brokers have issued 1 year price objectives for pSivida Corp.'s shares. Their predictions range from $5.00 to $13.00. On average, they expect pSivida Corp.'s share price to reach $8.00 in the next twelve months. View Analyst Ratings for pSivida Corp..

Who are some of pSivida Corp.'s key competitors?

Who are pSivida Corp.'s key executives?

pSivida Corp.'s management team includes the folowing people:

  • David J. Mazzo Ph.D., Independent Chairman of the Board (Age 59)
  • Nancy S. Lurker, President, Chief Executive Officer, Independent Director (Age 58)
  • Leonard S. Ross, Vice President - Finance, Principal Financial Officer (Age 66)
  • Debora A. Jorn, Executive Vice President - Corporate and Commercial Development (Age 59)
  • James J. Barry Ph.D., Independent Director (Age 57)
  • Jay S. Duker M.D., Independent Director (Age 57)
  • Douglas Evan Godshall M.B.A., Independent Director (Age 51)
  • Kristine Peterson, Independent Director (Age 57)
  • Michael W. Rogers, Independent Director (Age 57)

How do I buy pSivida Corp. stock?

Shares of pSivida Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is pSivida Corp.'s stock price today?

One share of pSivida Corp. stock can currently be purchased for approximately $1.26.

How big of a company is pSivida Corp.?

pSivida Corp. has a market capitalization of $57.02 million and generates $7.54 million in revenue each year. The company earns ($18,480,000.00) in net income (profit) each year or ($0.46) on an earnings per share basis. pSivida Corp. employs 22 workers across the globe.

How can I contact pSivida Corp.?

pSivida Corp.'s mailing address is 480 Pleasant St Ste B300, WATERTOWN, MA 02472-2468, United States. The company can be reached via phone at +1-617-9265000 or via email at [email protected]


MarketBeat Community Rating for pSivida Corp. (NASDAQ PSDV)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  124 (Vote Outperform)
Underperform Votes:  62 (Vote Underperform)
Total Votes:  186
MarketBeat's community ratings are surveys of what our community members think about pSivida Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for pSivida Corp. (NASDAQ:PSDV)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 6 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.00 (534.92% upside)

Consensus Price Target History for pSivida Corp. (NASDAQ:PSDV)

Price Target History for pSivida Corp. (NASDAQ:PSDV)

Analysts' Ratings History for pSivida Corp. (NASDAQ:PSDV)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/8/2017HC WainwrightReiterated RatingBuy$5.00N/AView Rating Details
11/8/2017LaidlawInitiated CoverageBuy$5.00N/AView Rating Details
6/14/2017Ladenburg Thalmann Financial ServicesSet Price TargetBuy$13.00MediumView Rating Details
6/14/2017Northland SecuritiesSet Price TargetBuy$10.00MediumView Rating Details
6/14/2017FBR & CoReiterated RatingBuyHighView Rating Details
5/30/2017Rodman & RenshawInitiated CoverageBuy$8.00HighView Rating Details
(Data available from 11/18/2015 forward)

Earnings

Earnings History and Estimates Chart for pSivida Corp. (NASDAQ:PSDV)

Earnings by Quarter for pSivida Corp. (NASDAQ:PSDV)

Earnings History by Quarter for pSivida Corp. (NASDAQ PSDV)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/5/2018N/AView Earnings Details
11/7/2017Q1 2018($0.15)($0.15)$0.74 million$0.39 millionViewN/AView Earnings Details
9/11/2017Q4 2017($0.16)($0.16)$0.48 million$0.70 millionViewN/AView Earnings Details
5/4/2017Q3 2017($0.15)($0.15)$0.36 million$0.59 millionViewListenView Earnings Details
11/7/2016Q1($0.19)($0.21)$0.30 million$0.28 millionViewListenView Earnings Details
9/12/2016Q4($0.13)($0.19)$2.40 million$0.30 millionViewListenView Earnings Details
5/5/2016Q3($0.20)($0.15)$1.75 million$0.32 millionViewN/AView Earnings Details
11/5/2015Q116($0.15)($0.17)$0.50 million$0.47 millionViewN/AView Earnings Details
9/9/2015Q415($0.14)($0.17)$0.60 million$0.41 millionViewN/AView Earnings Details
5/8/2015Q315($0.13)($0.17)$0.33 millionViewN/AView Earnings Details
2/5/2015($0.13)($0.14)$0.52 millionViewN/AView Earnings Details
11/7/2014Q3 14($0.12)$0.67$25.30 millionViewN/AView Earnings Details
9/9/2014Q414($0.15)($0.15)$0.29 millionViewN/AView Earnings Details
5/13/2014Q314($0.15)($0.03)$0.55 million$2.00 millionViewN/AView Earnings Details
2/7/2014Q214($0.13)($0.13)$430.00 million$0.59 millionViewN/AView Earnings Details
11/12/2013Q1($0.14)ViewListenView Earnings Details
9/25/2013Q413($0.12)($0.17)$0.65 million$0.49 millionViewN/AView Earnings Details
2/6/2013Q2 2013($0.11)$0.63 million$0.59 millionViewListenView Earnings Details
11/8/2012Q113($0.10)($0.11)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for pSivida Corp. (NASDAQ:PSDV)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20171($0.19)($0.19)($0.19)
Q3 20171($0.17)($0.17)($0.17)
Q4 20171($0.12)($0.12)($0.12)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for pSivida Corp. (NASDAQ:PSDV)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for pSivida Corp. (NASDAQ PSDV)

Insider Ownership Percentage: 2.59%
Institutional Ownership Percentage: 12.99%
Insider Trades by Quarter for pSivida Corp. (NASDAQ:PSDV)
Institutional Ownership by Quarter for pSivida Corp. (NASDAQ:PSDV)

Insider Trades by Quarter for pSivida Corp. (NASDAQ PSDV)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2017Nancy LurkerInsiderBuy56,700$1.76$99,792.00View SEC Filing  
1/4/2016Leonard S. RossVPSell5,000$4.70$23,500.00View SEC Filing  
12/22/2015Leonard S. RossVPSell33,950$5.39$182,990.50View SEC Filing  
12/22/2015Paul AshtonCEOSell120,000$5.39$646,800.00View SEC Filing  
10/1/2014Paul AshtonCEOSell10,000$4.27$42,700.00View SEC Filing  
9/2/2014Paul AshtonCEOSell10,000$4.78$47,800.00View SEC Filing  
8/1/2014Paul AshtonCEOSell10,000$4.37$43,700.00View SEC Filing  
7/1/2014Paul AshtonCEOSell10,000$4.32$43,200.00View SEC Filing  
6/19/2014Paul AshtonCEOSell7,000$4.00$28,000.00View SEC Filing  
6/17/2014Lori FreedmanVPSell7,900$4.00$31,600.00View SEC Filing  
6/17/2014Paul AshtonCEOSell7,700$4.00$30,800.00View SEC Filing  
6/13/2014Lori FreedmanVPSell11,700$4.02$47,034.00View SEC Filing  
6/13/2014Paul AshtonCEOSell11,800$4.02$47,436.00View SEC Filing  
10/1/2012Paul HopperDirectorBuy10,000$1.68$16,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for pSivida Corp. (NASDAQ:PSDV)

Latest Headlines for pSivida Corp. (NASDAQ PSDV)

Source:
DateHeadline
Edited Transcript of PSDV earnings conference call or presentation 7-Nov-17 1:30pm GMTEdited Transcript of PSDV earnings conference call or presentation 7-Nov-17 1:30pm GMT
finance.yahoo.com - November 9 at 11:54 AM
pSivida Corp.s (PSDV) "Buy" Rating Reaffirmed at HC WainwrightpSivida Corp.'s (PSDV) "Buy" Rating Reaffirmed at HC Wainwright
www.americanbankingnews.com - November 8 at 10:26 PM
pSivida Corp. (PSDV) Given Consensus Rating of "Buy" by AnalystspSivida Corp. (PSDV) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - November 8 at 11:58 AM
pSivida Corp. (PSDV) Releases  Earnings Results, Meets EstimatespSivida Corp. (PSDV) Releases Earnings Results, Meets Estimates
www.americanbankingnews.com - November 7 at 4:20 PM
pSivida Corp. Builds Momentum During First Quarter FY18; Continues Operating Milestone Execution - GlobeNewswire (press release)pSivida Corp. Builds Momentum During First Quarter FY18; Continues Operating Milestone Execution - GlobeNewswire (press release)
globenewswire.com - November 7 at 9:08 AM
pSivida Corp. Builds Momentum During First Quarter FY18; Continues Operating Milestone ExecutionpSivida Corp. Builds Momentum During First Quarter FY18; Continues Operating Milestone Execution
finance.yahoo.com - November 7 at 9:07 AM
pSivida Corp. to Host Earnings CallpSivida Corp. to Host Earnings Call
finance.yahoo.com - November 7 at 9:07 AM
PSivida reports 1Q lossPSivida reports 1Q loss
finance.yahoo.com - November 7 at 9:07 AM
ETFs with exposure to pSivida Corp. : November 3, 2017ETFs with exposure to pSivida Corp. : November 3, 2017
finance.yahoo.com - November 4 at 9:04 AM
pSivida Corp. (PSDV) Expected to Announce Quarterly Sales of $740,000.00pSivida Corp. (PSDV) Expected to Announce Quarterly Sales of $740,000.00
www.americanbankingnews.com - November 2 at 9:10 AM
-$0.15 EPS Expected for pSivida Corp. (PSDV) This Quarter-$0.15 EPS Expected for pSivida Corp. (PSDV) This Quarter
www.americanbankingnews.com - October 31 at 3:37 PM
Contrasting pSivida Corp. (PSDV) and Its CompetitorsContrasting pSivida Corp. (PSDV) and Its Competitors
www.americanbankingnews.com - October 31 at 1:06 PM
pSivida Corp. (PSDV) Set to Announce Earnings on TuesdaypSivida Corp. (PSDV) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - October 31 at 10:00 AM
ETFs with exposure to pSivida Corp. : October 23, 2017ETFs with exposure to pSivida Corp. : October 23, 2017
finance.yahoo.com - October 24 at 8:53 AM
pSivida Corp. Announces First Quarter Fiscal Year 2018 Financial Results Release Date and Conference Call InformationpSivida Corp. Announces First Quarter Fiscal Year 2018 Financial Results Release Date and Conference Call Information
finance.yahoo.com - October 19 at 7:44 AM
pSivida Corp. (PSDV) and The Competition Head-To-Head AnalysispSivida Corp. (PSDV) and The Competition Head-To-Head Analysis
www.americanbankingnews.com - October 18 at 8:18 PM
pSivida Corp. (PSDV) Given a $5.00 Price Target at HC WainwrightpSivida Corp. (PSDV) Given a $5.00 Price Target at HC Wainwright
www.americanbankingnews.com - October 15 at 10:20 PM
Biotech Stocks Ignite in the News on TuesdayBiotech Stocks Ignite in the News on Tuesday
finance.yahoo.com - October 11 at 6:44 AM
ETFs with exposure to pSivida Corp. : October 10, 2017ETFs with exposure to pSivida Corp. : October 10, 2017
finance.yahoo.com - October 11 at 6:44 AM
Nicox and pSivida enter strategic collaboration agreement to develop sustained release drug to lower intraocular ... - GlobeNewswire (press release)Nicox and pSivida enter strategic collaboration agreement to develop sustained release drug to lower intraocular ... - GlobeNewswire (press release)
globenewswire.com - October 10 at 2:55 AM
pSivida Corp. :PSDV-US: Earnings Analysis: Q4, 2017 By the Numbers : October 5, 2017pSivida Corp. :PSDV-US: Earnings Analysis: Q4, 2017 By the Numbers : October 5, 2017
finance.yahoo.com - October 5 at 5:41 PM
pSivida Corp. (PSDV) Given Buy Rating at HC WainwrightpSivida Corp. (PSDV) Given Buy Rating at HC Wainwright
www.americanbankingnews.com - September 27 at 7:28 PM
pSivida Partners with Global Pharmaceuticals Company to Develop Sustained Release Formulations of Glaucoma Drugs - GlobeNewswire (press release)pSivida Partners with Global Pharmaceuticals Company to Develop Sustained Release Formulations of Glaucoma Drugs - GlobeNewswire (press release)
globenewswire.com - September 27 at 8:22 AM
pSivida Partners with Global Pharmaceuticals Company to Develop Sustained Release Formulations of Glaucoma DrugspSivida Partners with Global Pharmaceuticals Company to Develop Sustained Release Formulations of Glaucoma Drugs
finance.yahoo.com - September 26 at 7:04 PM
pSivida Corp. (PSDV) Expected to Announce Earnings of -$0.15 Per SharepSivida Corp. (PSDV) Expected to Announce Earnings of -$0.15 Per Share
www.americanbankingnews.com - September 24 at 12:18 AM
ETFs with exposure to pSivida Corp. : September 18, 2017ETFs with exposure to pSivida Corp. : September 18, 2017
finance.yahoo.com - September 19 at 6:48 AM
pSivida Corp. :PSDV-US: Earnings Analysis: 2017 By the Numbers : September 15, 2017pSivida Corp. :PSDV-US: Earnings Analysis: 2017 By the Numbers : September 15, 2017
finance.yahoo.com - September 16 at 7:59 AM
pSivida (PSDV) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - SlideshowpSivida (PSDV) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow
seekingalpha.com - September 14 at 9:28 AM
PSivida reports 4Q lossPSivida reports 4Q loss
www.cnbc.com - September 13 at 8:00 AM
pSivida Corp. Achieves Significant Milestones Throughout FY 2017 ... - GlobeNewswire (press release)pSivida Corp. Achieves Significant Milestones Throughout FY 2017 ... - GlobeNewswire (press release)
globenewswire.com - September 12 at 8:53 AM
Is pSivida Corp (PSDV) Undervalued?Is pSivida Corp (PSDV) Undervalued?
finance.yahoo.com - September 12 at 8:52 AM
pSivida to Present at Rodman & Renshaw Annual Global Investment ConferencepSivida to Present at Rodman & Renshaw Annual Global Investment Conference
finance.yahoo.com - September 12 at 8:52 AM
Investor Network: pSivida Corp Shs Chess Depository Interests repr 1/40 Sh to Host Earnings CallInvestor Network: pSivida Corp Shs Chess Depository Interests repr 1/40 Sh to Host Earnings Call
finance.yahoo.com - September 12 at 8:52 AM
pSivida Corp. Achieves Significant Milestones Throughout FY 2017; Reports Fourth Quarter and Fiscal 2017 ResultspSivida Corp. Achieves Significant Milestones Throughout FY 2017; Reports Fourth Quarter and Fiscal 2017 Results
finance.yahoo.com - September 12 at 8:52 AM
Edited Transcript of PSDV earnings conference call or presentation 11-Sep-17 8:30pm GMTEdited Transcript of PSDV earnings conference call or presentation 11-Sep-17 8:30pm GMT
finance.yahoo.com - September 12 at 8:52 AM
pSivida Corp. (PSDV) Announces  Earnings ResultspSivida Corp. (PSDV) Announces Earnings Results
www.americanbankingnews.com - September 11 at 8:20 PM
pSivida Corp. (PSDV) Expected to Announce Quarterly Sales of $480,000.00pSivida Corp. (PSDV) Expected to Announce Quarterly Sales of $480,000.00
www.americanbankingnews.com - September 7 at 7:38 AM
pSivida Corp. to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Monday, September 11th - GlobeNewswire (press release)pSivida Corp. to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Monday, September 11th - GlobeNewswire (press release)
globenewswire.com - September 6 at 7:26 AM
pSivida Corp. to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Monday, September 11thpSivida Corp. to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Monday, September 11th
finance.yahoo.com - September 6 at 7:26 AM
pSivida Corp. (PSDV) Scheduled to Post Earnings on MondaypSivida Corp. (PSDV) Scheduled to Post Earnings on Monday
www.americanbankingnews.com - September 4 at 2:42 AM
pSivida Corp. (PSDV) Expected to Post Earnings of -$0.16 Per SharepSivida Corp. (PSDV) Expected to Post Earnings of -$0.16 Per Share
www.americanbankingnews.com - August 17 at 6:16 PM
pSivida (PSDV) Presents At Canaccord Genuity 37th Annual Growth Conference - SlideshowpSivida (PSDV) Presents At Canaccord Genuity 37th Annual Growth Conference - Slideshow
seekingalpha.com - August 13 at 4:07 AM
pSivida to Present at Canaccord Genuity Growth Conference on August 10, 2017 - GlobeNewswire (press release)pSivida to Present at Canaccord Genuity Growth Conference on August 10, 2017 - GlobeNewswire (press release)
globenewswire.com - August 3 at 7:05 AM
pSivida to Present at Canaccord Genuity Growth Conference on August 10, 2017pSivida to Present at Canaccord Genuity Growth Conference on August 10, 2017
finance.yahoo.com - August 2 at 6:49 AM
pSivida Corp. (NASDAQ:PSDV) Expected to Announce Quarterly Sales of $520,000.00pSivida Corp. (NASDAQ:PSDV) Expected to Announce Quarterly Sales of $520,000.00
www.americanbankingnews.com - August 1 at 8:05 AM
 Brokerages Expect pSivida Corp. (PSDV) to Post -$0.14 Earnings Per Share Brokerages Expect pSivida Corp. (PSDV) to Post -$0.14 Earnings Per Share
www.americanbankingnews.com - July 30 at 2:09 PM
Leading Retinal Specialists to Highlight pSividas Durasert for Treatment of Posterior Segment Uveitis at ... - GlobeNewswire (press release)Leading Retinal Specialists to Highlight pSivida's Durasert for Treatment of Posterior Segment Uveitis at ... - GlobeNewswire (press release)
globenewswire.com - July 18 at 7:36 AM
Leading Retinal Specialists to Highlight pSivida’s Durasert for Treatment of Posterior Segment Uveitis at Prestigious Ophthalmology ConferencesLeading Retinal Specialists to Highlight pSivida’s Durasert for Treatment of Posterior Segment Uveitis at Prestigious Ophthalmology Conferences
finance.yahoo.com - July 18 at 7:36 AM
pSivida: Spec Biotech With Major Buy Signals - Seeking AlphapSivida: Spec Biotech With Major Buy Signals - Seeking Alpha
seekingalpha.com - July 15 at 7:42 AM
$530,000.00 in Sales Expected for pSivida Corp. (NASDAQ:PSDV) This Quarter$530,000.00 in Sales Expected for pSivida Corp. (NASDAQ:PSDV) This Quarter
www.americanbankingnews.com - July 8 at 10:30 AM

Social Media

Financials

Chart

pSivida Corp. (NASDAQ PSDV) Chart for Saturday, November, 18, 2017
Loading chart…

This page was last updated on 11/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.